Expert report review

Medical expert testimony on appeal: what must the trial record show?

An appellate court reviews a decision to admit or exclude a medical expert for abuse of discretion, the standard the Supreme Court set in General Electric Co. v. Joiner in 1997. Under Federal Rule of Evidence 103 the losing party can claim error only if it objected in time and stated the ground, or made an offer of proof when its own physician was kept out. A physician's review of the opposing report gives counsel the grounds for that objection.

Closed trial transcript volumes rest on an appellate table while a physician waits in the gallery

How does an appellate court review a ruling on medical expert testimony?

For abuse of discretion. In General Electric Co. v. Joiner (1997) the Supreme Court applied that standard both to rulings that admit expert testimony and to rulings that exclude it, and rejected a stricter review of exclusions.

Robert K. Joiner worked as an electrician for the Water & Light Department in Thomasville, Georgia, starting in 1973. In 1991 he was diagnosed with small cell lung cancer. He sued Monsanto, which manufactured PCBs between 1935 and 1977, together with General Electric and Westinghouse, and claimed that exposure to PCBs and their derivatives, furans and dioxins, had promoted his cancer.

The federal district court in the Northern District of Georgia excluded the opinions of his experts as "subjective belief or unsupported speculation" and granted summary judgment to the defendants. The Eleventh Circuit applied "a particularly stringent standard of review" to the exclusion of expert testimony and reversed.

The Supreme Court reversed the Eleventh Circuit and remanded. Chief Justice Rehnquist wrote for the Court: "We hold that abuse of discretion is the appropriate standard." A court of appeals "may not categorically distinguish between rulings allowing expert testimony and rulings which disallow it." Justice Stevens concurred in part and dissented in part. He would have returned the case to the Eleventh Circuit to apply the correct standard itself.

The standard applies in the same way whichever side lost. A plaintiff whose causation expert was excluded and a defendant whose objection to the plaintiff's physician was overruled both have to show an abuse of discretion, measured against what the trial judge had before him when he ruled.

What did the Supreme Court check in the Joiner record?

The studies behind the experts' opinions. The Court compared each animal and human study with Joiner's exposure and disease and held that the district court could find them insufficient, individually or in combination.

The animal studies involved infant mice that had received "massive doses of PCBs injected directly into their peritoneums or stomachs," in a highly concentrated form. Joiner was an adult, and the fluid he worked with generally had a much smaller PCB concentration. The mice developed alveologenic adenomas, while Joiner had small-cell carcinoma. No study in the record showed adult mice developing cancer after exposure to PCBs.

The four epidemiological studies fared no better. The authors of the study of an Italian capacitor plant wrote that there were "apparently no grounds for associating lung cancer deaths" with exposure at the plant. The study of a Monsanto plant reported an increase that was not statistically significant, and its authors did not suggest a link to PCBs. A study of a Norwegian cable company made no mention of PCBs. The subjects of the Japanese Yusho study had been exposed to numerous potential carcinogens, including toxic rice oil.

Joiner's side relied on the statement in Daubert that the focus must be on methodology, not on conclusions. The Court answered that conclusions and methodology are not entirely distinct. Nothing in Daubert or in the Federal Rules of Evidence requires a court to admit an opinion "connected to existing data only by the ipse dixit of the expert," and a court may conclude that "there is simply too great an analytical gap between the data and the opinion proffered."

The appeal was decided on paper the parties had put before the district court: the studies and the experts' reliance on them. A physician who reviews the opposing medical report before trial makes the same comparison, opinion by opinion: which study or chart entry is cited, what it actually reports, and where the opinion goes beyond it.

What must an objection to the opposing medical expert say?

It must be made in time and on the record, and it must state the specific ground unless the ground was apparent from the context. Under Rule 103(a), a claim of error is preserved only on those terms.

Under Federal Rule of Evidence 103(a), a party may claim error in a ruling to admit or exclude evidence only if the error affects a substantial right of the party. If the ruling admits evidence, the party must, on the record, timely object or move to strike and state "the specific ground, unless it was apparent from the context."

For a medical expert the ground usually comes from Rule 702. Since December 1, 2023, the rule admits expert testimony if the proponent shows the court that it is more likely than not that the expert's knowledge will help the trier of fact, that the testimony is based on sufficient facts or data, that it is the product of reliable principles and methods, and that the opinion is a reliable application of those principles and methods to the facts of the case.

An objection that names the element and the gap gives the appellate court a question it can review. Two examples of such a ground: the causation opinion assumes a time of onset that no entry in the chart records, which goes to sufficient facts or data under 702(b); or the expert applied a guideline written for one patient population to a patient outside it, which goes to reliable application under 702(d). The reviewing physician's notes give the page of the report and the entry in the chart for each such point.

Who decides the question matters for the record. Under Rule 104(a), "The court must decide any preliminary question about whether a witness is qualified," whether a privilege exists or whether evidence is admissible. In Daubert the Supreme Court placed the reliability inquiry there: the trial judge makes "a preliminary assessment of whether the reasoning or methodology underlying the testimony is scientifically valid."

Does a pretrial ruling on the medical expert have to be renewed at trial?

Not if the ruling was definitive. Rule 103(b) says that once the court rules definitively on the record, before or at trial, a party need not renew an objection or offer of proof to preserve a claim of error.

Rule 103(b) reads: "Once the court rules definitively on the record" either before or at trial, "a party need not renew an objection or offer of proof to preserve a claim of error for appeal." The 2000 committee note calls renewal after a definitive ruling "more a formalism than a necessity."

The same note limits that protection. Where the trial court "appears to have reserved its ruling or to have indicated that the ruling is provisional," the note says it makes sense to require the party to bring the issue to the court's attention again. If the relevant facts and circumstances change materially after the advance ruling, the party needs a renewed and timely objection, an offer of proof or a motion to strike. If the opposing party violates the terms of the initial ruling, the objection has to be made when the evidence is offered.

Medical testimony can move away from the written report between the motion in limine and the witness stand: a newly cited article, a different reading of an imaging study, a revised timeline of the patient's symptoms. Each of those changes is a change in the facts on which the pretrial ruling rested. The lawyer who must object at that moment needs the report, the deposition and the chart side by side, and a reviewer who has already compared them can point to the departure as the testimony comes in.

What if the court excluded your own physician?

Make an offer of proof. Under Rule 103(a)(2), when a ruling excludes evidence, a party preserves the claim of error by informing the court of the substance of the evidence, unless the substance was apparent from the context.

Rule 103(c) gives the trial court two tools for this step. "The court may make any statement about the character or form of the evidence, the objection made, and the ruling." The court "may direct that an offer of proof be made in question-and-answer form." Under Rule 103(d), in a jury trial the court must, to the extent practicable, conduct the proceedings so that inadmissible evidence is not suggested to the jury by any means.

For a retained physician, much of the substance already exists in writing. Rule 26(a)(2)(B) of the Federal Rules of Civil Procedure requires a report with "a complete statement of all opinions the witness will express and the basis and reasons for them," the facts or data considered, the exhibits, the witness's qualifications with a list of publications from the previous 10 years, a list of cases with testimony during the previous 4 years and a statement of compensation.

In Joiner the Supreme Court could test the excluded opinions against the studies because the record contained the studies and showed how the experts used them. An offer of proof that states only the physician's conclusion leaves an appellate court with nothing to compare. An offer that attaches the report, identifies the chart entries and literature behind each opinion and, if the court directs, runs through questions and answers, puts the basis in front of the reviewing court.

Did the 2023 amendment to Rule 702 change what the objection should target?

Yes. The amended text states the preponderance standard, and the committee note calls rulings that treated the sufficiency of an expert's basis and the application of the method as questions of weight an incorrect application of the rules.

The amendment took effect on December 1, 2023. The committee note explains that expert testimony may not be admitted unless the proponent shows the court that each requirement is more likely than not met, the preponderance standard that applies to most admissibility requirements under Rule 104(a).

The note addresses a line of decisions directly. It says that "many courts have held" that the sufficiency of an expert's basis and the application of the methodology "are questions of weight and not admissibility," and it states: "These rulings are an incorrect application of Rules 702 and 104(a)."

Rule 702(d) was amended as well. According to the committee note, "each expert opinion must stay within the bounds of what can be concluded" from a reliable application of the expert's basis and methodology. A medical review tests exactly that boundary: a study of one patient group cited for another, a risk figure turned into a statement about this patient, a timeline that the nursing notes do not support. An objection that names the boundary the opinion crossed puts the 2023 standard into the trial record, where an appellate court can find it.

What if the opposing physician's opinion changes after the report?

The other side must supplement the report and the deposition testimony by the time pretrial disclosures under Rule 26(a)(3) are due. Information not disclosed as required can be excluded under Rule 37(c)(1) unless the failure was substantially justified or harmless.

Under Rule 26(e)(2), for an expert whose report is required, the duty to supplement extends both to information in the report and to information given during the expert's deposition. Any additions or changes must be disclosed by the time the party's pretrial disclosures under Rule 26(a)(3) are due.

Rule 26(a)(2)(D) sets the default calendar when the court has not set one. Expert disclosures are due at least 90 days before the date set for trial or for the case to be ready for trial. Evidence intended solely to contradict or rebut evidence on the same subject is due within 30 days after the other party's disclosure.

Rule 37(c)(1) enforces those duties. A party that fails to provide information or identify a witness as Rule 26(a) or (e) requires is not allowed to use that information or witness on a motion, at a hearing or at a trial, "unless the failure was substantially justified or is harmless." The court may instead, or in addition, order payment of reasonable expenses, inform the jury of the failure or impose other sanctions.

An objection to a new opinion at trial cites these dates and the disclosure the opinion is missing from. A review written when the report arrived records what the report said and what it left out, so the new opinion can be identified as new when it is offered.

Can an appellate court correct an error nobody objected to?

Under Rule 103(e), a court may take notice of a plain error affecting a substantial right even if the claim of error was not properly preserved. The rule sets no further test for using that power.

The text of Rule 103(e) is short: "A court may take notice of a plain error affecting a substantial right, even if the claim of error was not properly preserved." The general preservation rule in Rule 103(a) contains the same limit: the error must affect a substantial right of the party.

A party that objected in time and stated a ground asks the appellate court to review the ruling under the abuse of discretion standard from Joiner. A party that did not object asks the court to use a power the rule describes with the word "may." The first request rests on the record the party made, the second on the appellate court's decision to look past its absence.

What if the opposing medical testimony is admitted but weak?

Then the trial remedies apply: cross-examination, contrary evidence, instructions on the burden of proof, and a motion for judgment when the evidence cannot carry the case. The Supreme Court named these remedies in Daubert in 1993.

Daubert v. Merrell Dow Pharmaceuticals, decided June 28, 1993, arose from claims that Bendectin, a prescription anti-nausea drug, caused serious birth defects in Jason Daubert and Eric Schuller. Merrell Dow's expert, physician and epidemiologist Steven H. Lamm, reviewed more than 30 published studies involving over 130,000 patients and found that none had shown Bendectin to be a human teratogen. The plaintiffs' eight experts relied on in vitro and in vivo animal studies, on analyses of the drug's chemical structure and on reanalyses of published epidemiological studies.

The district court granted summary judgment, and the Ninth Circuit affirmed under the general acceptance test of Frye v. United States. The Supreme Court held that the Federal Rules of Evidence, not Frye, govern the admissibility of expert scientific testimony, vacated the judgment and remanded. The Court listed questions a trial judge may ask: whether the theory or technique can be and has been tested, whether it has been subjected to peer review and publication, its known or potential error rate, the existence of standards controlling its operation, and its acceptance in the relevant scientific community.

The Court also wrote that "Vigorous cross-examination, presentation of contrary evidence, and careful instruction on the burden of proof" are the traditional and appropriate means of attacking shaky but admissible evidence. Where the evidence is too thin for a reasonable juror to find a proposition more likely than not true, the court remains free to direct a judgment under Rule 50(a) or to grant summary judgment under Rule 56.

Each of these remedies leaves a record: the transcript of the cross-examination, the testimony of the rebuttal physician, the motion and the ruling on it. The physician's review supplies the questions for the cross-examination and the content of the rebuttal report.

What does IAE do when a medical expert ruling may reach appeal?

A physician from the IAE registry in the specialty of the care at issue checks the opposing medical report against the chart and Rule 702 and issues a signed review in up to 5 business days.

The IAE page on reviews of the opposing medical expert report is written for counsel who have received the other side's report in a malpractice, wrongful death or personal injury case. The reviewing physician tests each opinion against the chart and against Rule 702: sufficient facts or data, a reliable method and a reliable application of it to this patient. The review can be followed by a rebuttal report.

The work starts with the materials and a description of the task. The secretariat confirms receipt the same day. Within one business day IAE confirms the format, cost, deadline and the physician from the registry, and the client approves the candidate and the CV before work starts. The signed PDF is issued in up to 5 business days after the format and cost are confirmed, and a 48-hour rush is available for tight deadlines.

Registry members passed the collegial attestation of the council under the published Criteria Matrix, and the physician can be verified in the public registry by Member ID or QR code. The physician confirms in the document that he or she has no interest in the outcome of the case, and the materials are not passed to third parties without the client's consent. IAE is not a law firm and does not advise on case strategy; objections, offers of proof and appeals are decided by counsel, and neither IAE nor the reviewer guarantees the outcome.

Sources

Read also

All articles

Expert report review

Ready to discuss your case?

Send the materials: the secretariat will confirm the format, cost, deadline and the specialist within one business day.

Expertise request

Received

Cost and timeline estimate

WorkReview of an opinion
TimelineUp to 5 business days
ExpertIAE registry member